Recombinant Human Von Willebrand Factor (rhVWF): First-In-Human Study Evaluating Pharmacokinetics, Demonstrating Safety and Tolerability In Type 3 Von Willebrand Disease
- Resource Type
- Article
- Authors
- Suiter, Tobias; Laffan, Michael; Mannucci, Pier M.; Kempton, Christine L.; Romond, Edward H; Shapiro, Amy D.; Birschmann, Ingvild; Gill, Joan Cox; Ragni, Margaret V.; Turecek, Peter; Ewenstein, Bruce M.; BioScience, VrWF Study Team Baxter
- Source
- Blood; November 2010, Vol. 116 Issue: 21 p237-237, 1p
- Subject
- Language
- ISSN
- 00064971; 15280020
Suiter: Baxter BioScience: Employment. Laffan:Baxter BioScience: Consultancy. Mannucci:Baxter BioScience: Consultancy. Kempton:Baxter BioScience: Consultancy. Romond:Baxter BioScience: Consultancy. Shapiro: Baxter BioSci- ence: Consultancy. Birschmann:Baxter BioScience: Consultancy. Gill:Baxter BioScience: Consultancy. Ragni:Baxter BioScience: Consultancy. Turecek:Baxter BioScience: Employment. Ewenstein:Baxter Bioscience: Employment. Baxter BioScience:Baxter BioScience: Employment.